Home
Dr Reddys Laboratories Ltd Share Price History
Dr Reddys Laboratories Ltd
NSE : 12 Feb, 2025
1215.856.1 (0.5%)
Prev Close
1209.8
Open Price
1218.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1819297
Today's High / Low
1220.4 / 1202.8
52 WK High / Low
1421.5 / 1120.0
Market Price of Dr Reddys Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 75.83 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1257 |
| BVPS | 739.57 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 22.25 |
| Op. Profit Mgn % | 24.94 |
| Net Profit Mgn % | 15.47 |
| Debt to Equity % | 0.5 |
Latest Shareholding
Promoters Holdings Over Time
About Dr Reddys Laboratories Ltd
- Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
- Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
- The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
- Dr. Reddy's operates in markets across the globe.
- Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.
FAQs for Dr Reddys Laboratories Ltd Share Price History
What are the key events that typically impact Dr Reddys Laboratories Ltd's share price history?
Key events that impact Dr Reddys Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Dr Reddys Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Dr Reddys Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Dr Reddys Laboratories Ltd?
Dividends can influence Dr Reddys Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Dr Reddys Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Dr Reddys Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Dr Reddys Laboratories Ltd’s share price history?
To understand Dr Reddys Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
